ReviewCureus2025
Clinical Efficacy of Allogeneic Bone Plate Shell Technique for Alveolar Ridge Augmentation: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research interests and trends in alveolar ridge augmentation and visualization of articles from 1990 to 2024: a bibliometric analysis.The Saudi dental journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The allogeneic bone plate shell technique has emerged as a minimally invasive alternative to autogenous block grafting for alveolar ridge augmentation, aiming to reduce donor-site morbidity while maintaining predictable hard-tissue outcomes. This systematic review evaluated the clinical efficacy, dimensional stability, and implant performance of allogeneic cortical plates used with the shell technique in human patients requiring ridge augmentation before implant placement. A comprehensive electronic search across PubMed/MEDLINE, Scopus, Web of Science, Embase, EBSCOhost, and Google Scholar was conducted from inception to June 2025. Studies were eligible if they involved adult patients treated with an allogeneic shell-type augmentation and reported at least one of the following outcomes: linear or volumetric bone gain, graft resorption, implant survival, marginal bone loss, histological findings, or complications. Seven clinical studies met the inclusion criteria, comprising retrospective and prospective cohorts, case series, and one retrospective comparative study, with sample sizes ranging from 10 to 372 patients and more than 500 augmentation procedures in total. The technique was predominantly applied to horizontal or combined horizontal/vertical defects in the maxilla and mandible using thin allogeneic cortical plates fixed with microscrews and compartments filled with autogenous chips and/or xenogeneic granules. Reported horizontal gains generally ranged from approximately 2.4 to 4.8 mm, with graft resorption as low as 0.2 mm or 8%-9% in some series. Implant survival consistently ranged from 99.4% to 100%, and complications such as dehiscence or plate mobility were infrequent and usually manageable. Within the limitations of non-randomized evidence and clinical heterogeneity, allogeneic shell augmentation appears to provide predictable ridge reconstruction and high implant survival while eliminating autogenous donor-site morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.